Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- BGFV -6.5%, FULT -3.8%, IBKR -3.6%, PLXS -2% (lowers DecQ guidance, citing inventory corrections and weaker demand in Healthcare/Lifesciences and Industrial markets; also announces new $50 mln share repurchase program), CFG -1.9%, PNFP -1.7%, MANU -0.9%, USB -0.6%
Other news:
- DH -13.3% (CEO steps down reaffirms Q4 guidance)
- ALEC -7.7% (stock offering)
- GOL -7.4% (comments on media reports - is in discussions with its financial stakeholders to achieve the aforementioned consensual restructuring)
- INTR -6% (stock offering by selling shareholders)
- CVGW -5.6% (delays Q4 report expects revs below consensus; delays 10-K filing board says certain matters merit "enhanced evaluation"; also exploring sale of its Fresh Cut Business to F&S Fresh Foods)
- SPWR -2% (adopts restructuring plan to reduce operating costs due to slower sales)
- HLN -1.3% (GlaxoSmithKline completes sale of shares in Haleon)
- MS -1.1% (Direct Lending Fund commences 5 mln share IPO)
- BP -1% (appoints Murray Auchincloss as CEO; to acquire GETEC ENERGIE GmbH)
Analyst comments:
- ALLK -10.1% (downgraded to Hold from Buy at Jefferies)
- AXL -3.3% (downgraded to Sell from Neutral at UBS)
- DXC -3.1% (downgraded to Sell from Neutral at Citigroup)
- F -1.7% (downgraded to Neutral from Buy at UBS)
- FTNT -1.1% (downgraded to Equal Weight from Overweight at CapitalOne)